![An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential]()
An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic PotentialJay, S. M.; Murthy, A. C.; Hawkins, J. F.; Wortzel, J. R.; Steinhauser, M. L.; Alvarez, L. M.; Gannon, J.; Macrae, C. A.; Griffith, L. G.; Lee, R. T. · Circulation · 2013